Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Flucloxacillin sodium
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Flucloxacillin 500mg capsules
0501012G0AAABAB
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 576,717 |
|
Flucloxacillin 125mg/5ml oral solution
0501012G0AAAFAF
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 47,869 |
|
Flucloxacillin 250mg capsules
0501012G0AAAAAA
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 41,702 |
|
Flucloxacillin 250mg/5ml oral solution
0501012G0AAAGAG
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 36,497 |
|
Flucloxacillin 250mg/5ml oral solution sugar free
0501012G0AAAQAQ
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 13,790 |
|
Flucloxacillin 125mg/5ml oral solution sugar free
0501012G0AAAPAP
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 5,632 |
|
Flucloxacillin 1g powder for solution for injection vials
0501012G0AAAEAE
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 6 |
|
Flucloxacillin 250mg powder for solution for injection vials
0501012G0AAACAC
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 2 |
|
Flucloxacillin 500mg powder for solution for injection vials
0501012G0AAADAD
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 2 |
|
Floxapen 1g powder for solution for injection vials
0501012G0BBAGAE
|
Floxapen (Capsule/Injection) | Flucloxacillin sodium | Infections | No data available |
|
Floxapen 250mg capsules
0501012G0BBAAAA
|
Floxapen (Capsule/Injection) | Flucloxacillin sodium | Infections | No data available |
|
Floxapen 250mg powder for solution for injection vials
0501012G0BBAEAC
|
Floxapen (Capsule/Injection) | Flucloxacillin sodium | Infections | No data available |
|
Floxapen 500mg capsules
0501012G0BBABAB
|
Floxapen (Capsule/Injection) | Flucloxacillin sodium | Infections | No data available |
|
Floxapen 500mg powder for solution for injection vials
0501012G0BBAFAD
|
Floxapen (Capsule/Injection) | Flucloxacillin sodium | Infections | No data available |
|
Fluclomix 250 capsules
0501012G0BGACAA
|
Fluclomix | Flucloxacillin sodium | Infections | No data available |
|
Fluclomix 500 capsules
0501012G0BGADAB
|
Fluclomix | Flucloxacillin sodium | Infections | No data available |
|
Flucloxacillin 2g powder for solution for injection vials
0501012G0AAARAR
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | No data available |
|
Ladropen 250mg capsules
0501012G0BCAAAA
|
Ladropen | Flucloxacillin sodium | Infections | No data available |
|
Ladropen 500mg capsules
0501012G0BCABAB
|
Ladropen | Flucloxacillin sodium | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.